|
|
Volumn 25, Issue 9, 2010, Pages 1775-
|
|
Rasburicase in the treatment of hyperuricemia of newborns
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CREATININE;
RASBURICASE;
URIC ACID;
ANTIGOUT AGENT;
BIOLOGICAL MARKER;
URATE OXIDASE;
ABSENCE OF SIDE EFFECTS;
CREATININE BLOOD LEVEL;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
HUMAN;
HYPERURICEMIA;
KIDNEY INJURY;
LETTER;
NEWBORN;
PREMATURITY;
PRIORITY JOURNAL;
REHYDRATION;
SINGLE DRUG DOSE;
TUMOR LYSIS SYNDROME;
UREA NITROGEN BLOOD LEVEL;
URIC ACID BLOOD LEVEL;
URINE VOLUME;
VERY LOW BIRTH WEIGHT;
BLOOD;
FEMALE;
GESTATIONAL AGE;
LOW BIRTH WEIGHT;
MALE;
TREATMENT OUTCOME;
BIOLOGICAL MARKERS;
FEMALE;
GESTATIONAL AGE;
GOUT SUPPRESSANTS;
HUMANS;
HYPERURICEMIA;
INFANT, LOW BIRTH WEIGHT;
INFANT, NEWBORN;
INFANT, PREMATURE;
MALE;
TREATMENT OUTCOME;
URATE OXIDASE;
URIC ACID;
|
|
EID: 77955012985
PISSN: 0931041X
EISSN: None
Source Type: Journal
DOI: 10.1007/s00467-010-1515-0 Document Type: Letter |
|
Times cited : (6)
|
|
References (5)
|
